Clinical development of cancer vaccines - Nature Medicine This Review highlights insights from recent clinical trials and discusses critical factors for optimizing cancer vaccines, with a focus on proxies for vaccine efficacy, neoantigen selection, modular p...

New Review on #CancerVaccines: John Haanen and colleagues highlight insights from recent clinical trials and discuss critical factors for optimization, with a focus on proxies for efficacy, #neoantigen selection, modular platforms and early intervention
www.nature.com/articles/s41...

#UniversalBasicIncome
or
#CancerVaccines

Narrator: These would not be boondogles

The Cancer Vaccine Institute is proud to share a year-in-review that highlights the research, achievements, and progress made in 2025. Read our newsletter here: mailchi.mp/f1e9b3bb9637...

#CancerResearch #CancerVaccines

📚Personalized #CancerVaccines
Personalized #neoantigen vaccines target tumor-specific mutations to trigger strong T-cell responses with lower autoimmunity risk. Enabled by #NGS, #AI, immunopeptidomics&mRNA/LNP, neoantigens are moving faster to the clinic. ow.ly/QYZv50YbyYK

Take a deep dive into the rapidly evolving world of therapeutic #CancerVaccines with Dr. Elias Sayour and find out why he is so excited about upcoming developments.

Listen now 🔉 buff.ly/v17FleW

#OncSky #CancerTherapy

Recent advances in therapeutic cancer vaccines - Nature Reviews Cancer Cancer prevention vaccines have reduced cancer-related mortalities, yet therapeutic cancer vaccine development and clinical translation continues to face challenges. Here, Zaidi, Jaffee and Yarchoan summarize the failures of cancer vaccines of the past, to highlight recent advancements in the field.

🥳 Our 7th most downloaded #REVIEW in 2025:

Recent advances in therapeutic cancer vaccines

#cancervaccines @NatResCancer
#NRCtop10of2025

ErVimmune raises 17m euros in funding to develop cancer vaccine - PharmaTimes The vaccine could be created as a ready-to-use product, rather than needing to be personalised

#vaccinedevelopment #ErVimmune #biotech #cancervaccine #readytousevaccine #personalisedvaccines #celltherapies #cancervaccines #cancervaccinecandidate #ErVac01 #immunotherapies #coldtumours #triplenegativebreastcancer #ovariancancer #offtheshelfcancervaccine #difficulttotreatcancers
zurl.co/Z94ou

Check the latest about the #Vaccines
www.mdpi.com/2673-9992/42...

The report collected the accepted abstracts from the 3rd International Online Conference on Vaccines

Chaired by Sara Louise Cosby
Organized by the Vaccines journal from MDPI
#IOCV2025 #VaccineResearch #Immunization #CancerVaccines

Global Summit on Cancer Research and Novel Drug Development The Global Summit on Cancer Research and Novel Drug Development (Cancer Meet-2026) will take place from March 16-18, 2026, in Barcelona, Spain, bringing

Global Summit on Cancer Research and Novel Drug Development
March 16-18, 2026
Barcelona, Spain

www.vydya.com/events/cance...

#CancerResearch #CancerTreatment #CancerVaccines
#HematologyConference

It's day 1 of our 2025 #AdventCalendar!! 🎄

Starting with a look back at the @nhsengland.bsky.social #CancerVaccineLaunchPad, which continued to expand this year.

The #CVLP is a ground-breaking programme, speeding up patient access to trials of innovative #CancerVaccines - bit.ly/4cQJeMk

Personalized Cancer Vaccines Are Almost Here—But Federal Funding Cuts Could Derail Them Vaccines based on mRNA can be tailored to target a cancer patient’s unique tumor mutations. But crumbling support for cancer and mRNA vaccine research has endangered this promising therapy

#CancerVaccines #PancreaticCancer #FundCancerResearch

#BREAKING Important update on progress of research & trials on #mRNAVaccines for pancreatic cancer.

These trials are at risk b/o funding cuts to NIH

Fund Cancer not #Trump'sBallroom and Argentina.

www.scientificamerican.com/article/pers...

Welcoming Dr. Natasha Hunter as Director of Clinical Trials at CVI We are thrilled to announce that Dr. Natasha Hunter, MD, has been appointed Director of Clinical Trials at the Cancer Vaccine Institute (CVI).Dr. Hunter is a translational breast cancer researcher and...

Welcome Dr. Natasha Hunter, MD, as CVI’s new Director of Clinical Trials! 👏

She’s leading phase II trials of our cancer vaccines + advancing translational science to improve patient outcomes.

More here: www.uwcvi.org/post/welcomi...
#CancerVaccines #ClinicalTrials #CancerResearch

🧬 Therapeutic cancer vaccines are back in focus! Advances in neo-antigen T cells, dendritic cell biology, and mRNA tech are paving the way for next-gen immunotherapy.

Read the Open Access review: https://bit.ly/4cefxGm

#CancerVaccines #Immunotherapy #mRNA #Oncology

Immune-Modulatory and mRNA-Based Cancer Vaccines Could Boost Benefit With ICIs Across Solid Tumors | OncLive Three experts spotlight key trials from the 2025 ESMO Congress investigating novel cancer vaccines across solid tumors.

Immune-Modulatory and mRNA-Based #CancerVaccines Could Boost Benefit With ICIs Across #SolidTumors

Watch the full video and read the article here!
www.onclive.com/view/immune-...

Fantastic moment at #iMig2025 — PhD student Jessica Boulter presented her work showing that personalised cancer vaccines may be feasible for mesothelioma. A major step toward new immunotherapy options.
#Mesothelioma #CancerResearch #Immunotherapy #CancerVaccines

Cancer Vaccines in Focus at AACR-NCI-EORTC Conference - OncoDaily Cancer Vaccines in Focus at AACR-NCI-EORTC Conference / AACR, cancer, June-Young Koh, OncoDaily, Oncology, Patrick Ott, Stephane Champiat, Vinod P. Balachandran

Cancer Vaccines in Focus at AACR-NCI-EORTC Conference

@theaacr.bsky.social @eortc.org

oncodaily.com/voices/cance...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #AACR #NCI #EORTC #CancerVaccines

#ESMO25: Are personalised #CancerVaccines the next frontier or an elusive goal? Catherine Wu discusses the exciting potential of genomics-guided personalised vaccines and some of the related challenges.
#ESMODailyReporter 👉 https://ow.ly/aMxi50Xgn37

#ImmunoOncology

#ESMO25: #CancerVaccines may be approaching prime time after decades of missed promises. @DoniaMarco discusses how connecting the dots between advances in major areas of vaccine research could deliver a long-promised breakthrough.
#ESMODailyReporter 🔗 https://ow.ly/rWB250XeyHs

Dr. Nora Disis had the honor of speaking on stage at the 14th Annual Benefit Show hosted by In Concert for Cancer, an unforgettable evening filled with powerful performances and heartfelt stories. Thank you to everyone who came together to support our work. #CancerVaccines #CVI

After 20 years of relentless research, ovarian cancer vaccines are within reach.
But with federal funding in decline, we need your help to keep momentum alive.
Let’s make ovarian cancer history—together.
💙 Support the work: www.uwcvi.org/donate-now
#OvarianCancer #CancerVaccines #ResearchMatters

Thank you, Dr. Elizabeth Jaffee @jhu.edu #KimmelCancerCenter for presenting our
#GrandRounds Koenigsberg Lecture on the role of #cancervaccines in enhancing #antitumor immune responses in patients who have not yet benefited from immune #checkpointtherapy.
➡️http://youtube.com/watch?v=kAruGP-ipYc

Vaccines Weekly Update – August 29th 2025 🧬 This Week in Vaccine Research: Shingles, Liver Cancer, Universal Flu & COVID-19 Updates & More This week’s Vaccine Research […] The post Vaccines Weekly Update – August 29th 2025 appeared first on LucidQuest Ventures.

FYI: LucidQuest Views >>> Vaccines Weekly Update – August 29th 2025 #News #cancervaccines #Chikungunya #COVID19Vaccines Comment below!

Vaccines Weekly Update – August 29th 2025 🧬 This Week in Vaccine Research: Shingles, Liver Cancer, Universal Flu & COVID-19 Updates & More This week’s Vaccine Research […] The post Vaccines Weekly Update – August 29th 2025 appeared first on LucidQuest Ventures.

ICYMI: LucidQuest Views >>> Vaccines Weekly Update – August 29th 2025 #News #cancervaccines #Chikungunya #COVID19Vaccines Comment below!

Vaccines Weekly Update – August 29th 2025 🧬 This Week in Vaccine Research: Shingles, Liver Cancer, Universal Flu & COVID-19 Updates & More This week’s Vaccine Research […] The post Vaccines Weekly Update – August 29th 2025 appeared first on LucidQuest Ventures.

LucidQuest Views >>> Vaccines Weekly Update – August 29th 2025 #News #cancervaccines #Chikungunya #COVID19Vaccines Comment below!

Memory T Cells, Recombinant Listeria monocytogenes, and Cancer Vaccines.
Amarante-Mendes, Gustavo P, Loza, Maribel Limachi et al.
Paper
Details
#MemoryTCells #ListeriaMonocytogenes #CancerVaccines

Mr Jonathan Huston MLA meets with NCARD researchers and staff during a roundtable discussion on asbestos-related disease research

Thank you to Mr Jonathan Huston MLA for visting NCARD to hear about our work in #mesothelioma research, #cancervaccines, clinical trials & equity-focused Aboriginal partnerships.
#WAHealth #AsbestosAwareness #HealthPolicy #NCARDresearch

Looking forward to talking about #cancervaccines to *all* @CRUK research and innovation staff this afternoon at their fabulous away-day. Actually I’m a bit nervous😬

#Medsky🧪 #oncosky #publichealth Crucial concepts in understanding #cancervaccines . Vaccines have had a major impact on the control of #infectiousdisease, most recently by helping to combat the #COVID19pandemic.

Huge congratulations to our very own @drlennardlee.bsky.social for winning the UK Oncology Forum award for his work on #CancerVaccines! 🏆🎉

We’re proud to have you as part of #CIO!